nejm glp 1 Discovery of GLP-1–Based Drugs for the Treatment of Obesity nejm glp 1 More Evidence
Description
This case highlights the need for gradual insulin tapering and close monitoring while transitioning from insulin therapy to GIP/GLP-1 receptor agonists.
10-Meal GLP-1 Friendly Starter Pack
Without insurance coverage, Ozempic costs
Both claims shaped funding priorities, training pipelines, and which lines of work got taken seriously
